Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1948 1
1950 1
1951 2
1952 1
1955 1
1957 1
1958 1
1959 3
1960 2
1961 1
1962 2
1963 7
1964 3
1965 9
1966 3
1967 4
1968 4
1969 9
1970 8
1971 12
1972 13
1973 13
1974 19
1975 25
1976 43
1977 61
1978 46
1979 98
1980 74
1981 98
1982 83
1983 113
1984 111
1985 93
1986 125
1987 139
1988 167
1989 154
1990 129
1991 176
1992 170
1993 186
1994 143
1995 152
1996 138
1997 127
1998 135
1999 158
2000 196
2001 221
2002 241
2003 210
2004 254
2005 285
2006 288
2007 306
2008 338
2009 355
2010 413
2011 433
2012 478
2013 495
2014 545
2015 596
2016 613
2017 595
2018 712
2019 582
2020 742
2021 779
2022 730
2023 745
2024 270

Text availability

Article attribute

Article type

Publication date

Search Results

13,232 results

Results by year

Filters applied: . Clear all
Page 1
Duchenne muscular dystrophy.
Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A. Duan D, et al. Nat Rev Dis Primers. 2021 Feb 18;7(1):13. doi: 10.1038/s41572-021-00248-3. Nat Rev Dis Primers. 2021. PMID: 33602943 Free PMC article. Review.
Duchenne muscular dystrophy is a severe, progressive, muscle-wasting disease that leads to difficulties with movement and, eventually, to the need for assisted ventilation and premature death. ...Recent studies have greatly deepened our understanding of the p …
Duchenne muscular dystrophy is a severe, progressive, muscle-wasting disease that leads to difficulties with movement a …
Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update.
Sun C, Shen L, Zhang Z, Xie X. Sun C, et al. Genes (Basel). 2020 Jul 23;11(8):837. doi: 10.3390/genes11080837. Genes (Basel). 2020. PMID: 32717791 Free PMC article. Review.
Being the most common and most severe type of muscular dystrophy, Duchenne muscular dystrophy (DMD), is caused by mutations in the X-linked dystrophin gene. ...
Being the most common and most severe type of muscular dystrophy, Duchenne muscular dystrophy (DMD), is caused by mutat …
Duchenne muscular dystrophy.
Yiu EM, Kornberg AJ. Yiu EM, et al. J Paediatr Child Health. 2015 Aug;51(8):759-64. doi: 10.1111/jpc.12868. Epub 2015 Mar 9. J Paediatr Child Health. 2015. PMID: 25752877 Review.
Duchenne muscular dystrophy, an X-linked disorder, has an incidence of one in 5000 boys and presents in early childhood with proximal muscle weakness. ...The use of corticosteroids, non-invasive respiratory support, and active surveillance and management of a …
Duchenne muscular dystrophy, an X-linked disorder, has an incidence of one in 5000 boys and presents in early childhood …
CRISPR-Cas9 Gene Therapy for Duchenne Muscular Dystrophy.
Happi Mbakam C, Lamothe G, Tremblay G, Tremblay JP. Happi Mbakam C, et al. Neurotherapeutics. 2022 Apr;19(3):931-941. doi: 10.1007/s13311-022-01197-9. Epub 2022 Feb 14. Neurotherapeutics. 2022. PMID: 35165856 Free PMC article. Review.
The application of this technique for the correction of different mutations found in the Duchenne muscular dystrophy (DMD) gene led to the development of several potential therapeutic approaches for DMD patients. The mutations responsible for Duchenne …
The application of this technique for the correction of different mutations found in the Duchenne muscular dystrophy (D …
Duchenne muscular dystrophy.
Annexstad EJ, Lund-Petersen I, Rasmussen M. Annexstad EJ, et al. Tidsskr Nor Laegeforen. 2014 Aug 5;134(14):1361-4. doi: 10.4045/tidsskr.13.0836. eCollection 2014 Aug 5. Tidsskr Nor Laegeforen. 2014. PMID: 25096430 Free article. Review. English, Norwegian.
BACKGROUND: Duchenne muscular dystrophy is one of the most severe muscle diseases to affect children. ...Active intervention in response to signs of respiratory or cardiac failure is important. More causal treatment of Duchenne muscular dystr …
BACKGROUND: Duchenne muscular dystrophy is one of the most severe muscle diseases to affect children. ...Active interve …
Duchenne muscular dystrophy: pathogenesis and promising therapies.
Chang M, Cai Y, Gao Z, Chen X, Liu B, Zhang C, Yu W, Cao Q, Shen Y, Yao X, Chen X, Sun H. Chang M, et al. J Neurol. 2023 Aug;270(8):3733-3749. doi: 10.1007/s00415-023-11796-x. Epub 2023 Jun 1. J Neurol. 2023. PMID: 37258941 Review.
Duchenne muscular dystrophy (DMD) is a severe, progressive, muscle-wasting disease, characterized by progressive deterioration of skeletal muscle that causes rapid loss of mobility. ...
Duchenne muscular dystrophy (DMD) is a severe, progressive, muscle-wasting disease, characterized by progressive deteri …
Emerging therapies for Duchenne muscular dystrophy.
Markati T, Oskoui M, Farrar MA, Duong T, Goemans N, Servais L. Markati T, et al. Lancet Neurol. 2022 Sep;21(9):814-829. doi: 10.1016/S1474-4422(22)00125-9. Epub 2022 Jul 15. Lancet Neurol. 2022. PMID: 35850122 Review.
Duchenne muscular dystrophy is an X-linked disease caused by the absence of functional dystrophin in the muscle cells. ...The difficulties of clinical development that arise from both the rarity and variability of Duchenne muscular dystrophy …
Duchenne muscular dystrophy is an X-linked disease caused by the absence of functional dystrophin in the muscle cells. …
Therapeutic developments for Duchenne muscular dystrophy.
Verhaart IEC, Aartsma-Rus A. Verhaart IEC, et al. Nat Rev Neurol. 2019 Jul;15(7):373-386. doi: 10.1038/s41582-019-0203-3. Nat Rev Neurol. 2019. PMID: 31147635 Review.
Duchenne muscular dystrophy (DMD) is caused by the lack of functional dystrophin protein. ...
Duchenne muscular dystrophy (DMD) is caused by the lack of functional dystrophin protein. ...
CRISPR Therapeutics for Duchenne Muscular Dystrophy.
Erkut E, Yokota T. Erkut E, et al. Int J Mol Sci. 2022 Feb 6;23(3):1832. doi: 10.3390/ijms23031832. Int J Mol Sci. 2022. PMID: 35163754 Free PMC article. Review.
Duchenne muscular dystrophy (DMD) is an X-linked recessive neuromuscular disorder with a prevalence of approximately 1 in 3500-5000 males. ...
Duchenne muscular dystrophy (DMD) is an X-linked recessive neuromuscular disorder with a prevalence of approximately 1 …
[Update on Duchenne muscular dystrophy].
Leiva-Cepas F, Montaño Martínez A, López-López I. Leiva-Cepas F, et al. Semergen. 2021 Oct;47(7):472-481. doi: 10.1016/j.semerg.2021.06.008. Epub 2021 Aug 18. Semergen. 2021. PMID: 34417099 Spanish.
Duchenne muscular dystrophy, DMD*(ICD-9-C: 359.1; ICD-10-ES: G71.01, ORPHA: 98896) is a dystrophic type, autosomal recessive myopathy linked to the X chromosome, low incidence 1/3300, with full penetrance and multi-organ involvement (neuro-muscular, respirato …
Duchenne muscular dystrophy, DMD*(ICD-9-C: 359.1; ICD-10-ES: G71.01, ORPHA: 98896) is a dystrophic type, autosomal rece …
13,232 results
You have reached the last available page of results. Please see the User Guide for more information.